PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW128535View Pathway |
drug action
Levofloxacin Action PathwayHaemophilus influenzae
Levofloxacin is a fluoroquinolone antibiotic used to treat infections caused by susceptible bacteria of the upper respiratory tract, skin and skin structures, urinary tract, and prostate, as well as for post-exposure treatment of inhaled anthrax and the plague. Levofloxacin inhibits DNA gyrase (topoisomerase II) and topoisomerase IV. These proteins prevent supercoiling in bacterial DNA. The inhibition of DNA gyrase (topoisomerase II) and topoisomerase IV causes supercoiling of the bacterial DNA. This prevents DNA replication.
|
Creator: Ray Kruger Created On: September 01, 2023 at 15:57 Last Updated: September 01, 2023 at 15:57 |
PW145225View Pathway |
drug action
Levofloxacin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:21 Last Updated: October 07, 2023 at 15:21 |
PW176080View Pathway |
Levofloxacin Predicted Metabolism Pathway newHomo sapiens
Metabolites of Levofloxacin are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:48 Last Updated: November 29, 2023 at 13:48 |
PW145648View Pathway |
drug action
Levoketoconazole Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:18 Last Updated: October 07, 2023 at 16:18 |
PW127858View Pathway |
drug action
Levoleucovorin Action PathwayHomo sapiens
Levoleucovorin is a folate analog, used to counter the adverse effects of folic acid antagonists. Commonly used in combination with chemotherapy and 5-fluorouracil to treat patients with colorectal cancer. Folic acid is necessary in order to produce purines, pyrimidines and methionine required for DNA synthesis and replication. Once transported into the mitochondria, levoleucovorin acts to inhibit serine hydroxymethyltransferase. Without this enzyme, this halts the DNA synthesis and replication process as 5,10-Methylene-THF cannot be made. 5,10 Methylene THF is an intermediate in many amino acid pathways, such as methionine synthesis. It is also used in thymidine synthesis which is a nucleoside needed for DNA replication.
|
Creator: Selena Created On: June 11, 2023 at 20:35 Last Updated: June 11, 2023 at 20:35 |
PW146396View Pathway |
drug action
Levoleucovorin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:06 Last Updated: October 07, 2023 at 18:06 |
PW146323View Pathway |
drug action
Levomefolic acid Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:56 Last Updated: October 07, 2023 at 17:56 |
PW132493View Pathway |
Levomenol Drug MetabolismHomo sapiens
Levomenol is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Levomenol passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:05 Last Updated: September 21, 2023 at 22:05 |
PW146592View Pathway |
drug action
Levomenol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:35 Last Updated: October 07, 2023 at 18:35 |
PW000654View Pathway |
drug action
Levomethadyl Acetate Action Action PathwayHomo sapiens
Levomethadyl acetate (also known as LAAM) is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, levomethadyl acetate is more active and more toxic than morphine. Levomethadyl acetate can bind to mu-type opioid receptor to activate associated G-protein in the sensory neurons of central nervous system (CNS), which will reduce the level of intracellular cAMP by inhibiting adenylate cyclase. The binding of levomethadyl acetate will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter. Therefore, methadyl acetate can reduce nerve conduction and decrease neurotransmitter release; so that perception of pain signals can be blocked. Levomethadyl acetate can also open calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist) to reduce neuronal excitability as well as lead to hyperpolarization.
|
Creator: WishartLab Created On: April 21, 2014 at 06:17 Last Updated: April 21, 2014 at 06:17 |